# EDGAR Filing Document

**Accession Number:** 0001485894
**File Stem:** 0001193125-26-079302
**Filing Date:** 2026-2
**Character Count:** 3984
**Document Hash:** 29138b39bac5cb96b638caadc0db1a68
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-079302.hdr.sgml**: 20260227

**ACCESSION NUMBER**: 0001193125-26-079302

**CONFORMED SUBMISSION TYPE**: 497

**PUBLIC DOCUMENT COUNT**: 11

**FILED AS OF DATE**: 20260227

**DATE AS OF CHANGE**: 20260227

**EFFECTIVENESS DATE**: 20260227

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** J.P. Morgan Exchange-Traded Fund Trust
- **CENTRAL INDEX KEY:** 0001485894

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** 497
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-191837
- **FILM NUMBER:** 26692720

**BUSINESS ADDRESS:**
- **STREET 1:** 390 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** (800) 480-4111

**MAIL ADDRESS:**
- **STREET 1:** 390 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

## Series and Classes Contracts Data

### JPMorgan Equity Focus ETF (Series ID: S000079812)

---

|  |  |  |
|:---|:---|:---|
| Class Name                | Ticker Symbol | Class ID   |
| JPMorgan Equity Focus ETF | JPEF          | C000241195 |

---

## Series and Classes Contracts Data

### JPMorgan Equity Focus ETF (Series ID: S000079812)

| Class ID   | Class Name                | Ticker Symbol   |
|:---|:---|:---|
| C000241195 | JPMorgan Equity Focus ETF | JPEF            |

?xml version='1.0' encoding='ASCII'? J.P. Morgan Exchange-Traded Fund Trust

------

#### J.P. MORGAN EXCHANGE-TRADED FUNDS

#### JPMorgan Equity Focus ETF
*(the "Fund")* 

*(a series of J.P. Morgan Exchange-Traded Fund Trust)* 

#### Supplement dated February 27, 2026

#### to the current Summary Prospectus and Prospectus
Effective March 1, 2026, the following changes will be made to the Fund's Summary Prospectus and Prospectus:

The fourth paragraph under the "**What are the Fund's main investment strategies?**" section of the Fund's Summary Prospectus and Prospectus and under the "**More About the Funds – Additional Information About the Funds' Investment Strategies – Equity Focus ETF**" section of the Fund's Prospectus shall be deleted and replaced with the following:

Derivatives, which are instruments that have a value based on another instrument, exchange rate or index, may be used as substitutes for investments in certain securities. The Fund may use derivatives, primarily futures contracts, to gain exposure to its index or certain securities in its index, or to more effectively gain targeted equity exposure from its cash positions. To the extent the Fund invests in index futures with exposure to securities in the index, it may have the effect of increasing the Fund's exposure to a relatively small number of securities, making the Fund's Shares more sensitive to the economic results of those securities.

In addition, the Fund will be subject to "Significant Holdings Risk" and the following will be added under the "**The Fund's Main Investment Risks**" section of the Fund's Summary Prospectus and Prospectus and under the "**More About the Funds – Investment Risks**" section of the Fund's Prospectus:

*Significant Holdings Risk*. Although the Fund is considered "diversified" under applicable law, a relatively large portion of its portfolio at times may be invested in a relatively small number of securities, or investments (including futures) whose performance relates in part to the economic results of a relatively small number of securities, or in a combination of the foregoing. These investments increase the risk that the value of the Fund's Shares is more sensitive to economic results of the underlying securities. The value of the Shares of the Fund may also be more volatile than a fund that allocates its investments to a larger number of smaller positions or to investments whose performance is related to a larger number of securities.

#### INVESTORS SHOULD RETAIN THIS SUPPLEMENT WITH THE

#### SUMMARY PROSPECTUS AND PROSPECTUS FOR FUTURE REFERENCE

#### SUP-EFETF-226